The incidence of epileptic manifestations occurring as a complication of Insulin Coma Therapy is compared in three groups of patients receiving ( a ) insulin alone, ( b ) insulin and chlorpromazine, and ( c ) insulin, chlorpromazine and sodium hydantoin. Our results, statistically significant at the 1 per cent. level, show that in such patients chlorpromazine has epileptogenic properties.
The
... [Show full abstract] literature on the relationship between epilepsy and chlorpromazine is discussed.